Quince Therapeutics, Inc. (QNCX): SC 13G/A filed Feb 14, 2024

Form type

SC 13G/A

Filing date

Feb 14, 2024

Accession number

0001214659-24-002876

Filer

Quince Therapeutics, Inc. (CIK 1662774)